Rapid activation of endothelial NO synthase by estrogen: Evidence for a steroid receptor fast-action complex (SRFC) in caveolae

Ken L. Chambliss, Philip W. Shaul

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Estrogen has important atheroprotective and vasoactive properties related to its capacity to stimulate nitric oxide (NO) production by endothelial NO synthase. Previous work has shown that these effects are mediated by estrogen receptor (ER) α functioning in a nongenomic manner via calcium-dependent, MAP kinase-dependent mechanisms. Recent studies have demonstrated that estradiol (E2) activates eNOS in isolated endothelial plasma membranes in the absence of added calcium, calmodulin or eNOS cofactors. Studies of blockade by ICI 182,780 and by ERα antibody, and also immunoidentification experiments indicate that the process is mediated by a subpopulation of plasma membrane-associated ERα. Fractionation of endothelial cell plasma membranes has further revealed that ERα protein is localized to caveolae, and that E2 causes stimulation of eNOS in isolated caveolae which is ER-dependent and calcium-dependent, whereas noncaveolae membranes are insensitive. Furthermore, in intact endothelial cells the activation of eNOS by E2 is prevented by pertussis toxin, and exogenous GDPβS inhibits the response in isolated plasma membranes. Coimmunoprecipitation studies have shown that E2 exposure causes interaction between ERα and Gαi on the plasma membrane, and eNOS activation by E2 is enhanced by overexpression of Gαi and attenuated by expression of a protein regulator of G protein signaling (RGS), RGS4. Thus, a subpopulation of ERα is localized to caveolae in endothelial cells, where they are coupled via Gαi to eNOS in a functional signaling module. Emphasizing the dependence on cell surface-associated receptors, these observations provide evidence for the existence of a steroid receptor fast-action complex, or SRFC, in caveolae.

Original languageEnglish (US)
Pages (from-to)413-419
Number of pages7
JournalSteroids
Volume67
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Caveolae
Nitric Oxide Synthase Type III
Steroid Receptors
Cell membranes
Estrogen Receptors
Estrogens
Chemical activation
Cell Membrane
Endothelial cells
Endothelial Cells
Calcium
RGS Proteins
Pertussis Toxin
Cell Surface Receptors
Calmodulin
Fractionation
Estradiol
Nitric Oxide
Phosphotransferases
Membranes

Keywords

  • Caveolae
  • Endothelium
  • Estrogen
  • Estrogen receptor
  • G protein
  • Nitric oxide synthase
  • Steroid

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Cite this

Rapid activation of endothelial NO synthase by estrogen : Evidence for a steroid receptor fast-action complex (SRFC) in caveolae. / Chambliss, Ken L.; Shaul, Philip W.

In: Steroids, Vol. 67, No. 6, 2002, p. 413-419.

Research output: Contribution to journalArticle

@article{e29f93c581614d188607adea8f4ada39,
title = "Rapid activation of endothelial NO synthase by estrogen: Evidence for a steroid receptor fast-action complex (SRFC) in caveolae",
abstract = "Estrogen has important atheroprotective and vasoactive properties related to its capacity to stimulate nitric oxide (NO) production by endothelial NO synthase. Previous work has shown that these effects are mediated by estrogen receptor (ER) α functioning in a nongenomic manner via calcium-dependent, MAP kinase-dependent mechanisms. Recent studies have demonstrated that estradiol (E2) activates eNOS in isolated endothelial plasma membranes in the absence of added calcium, calmodulin or eNOS cofactors. Studies of blockade by ICI 182,780 and by ERα antibody, and also immunoidentification experiments indicate that the process is mediated by a subpopulation of plasma membrane-associated ERα. Fractionation of endothelial cell plasma membranes has further revealed that ERα protein is localized to caveolae, and that E2 causes stimulation of eNOS in isolated caveolae which is ER-dependent and calcium-dependent, whereas noncaveolae membranes are insensitive. Furthermore, in intact endothelial cells the activation of eNOS by E2 is prevented by pertussis toxin, and exogenous GDPβS inhibits the response in isolated plasma membranes. Coimmunoprecipitation studies have shown that E2 exposure causes interaction between ERα and Gαi on the plasma membrane, and eNOS activation by E2 is enhanced by overexpression of Gαi and attenuated by expression of a protein regulator of G protein signaling (RGS), RGS4. Thus, a subpopulation of ERα is localized to caveolae in endothelial cells, where they are coupled via Gαi to eNOS in a functional signaling module. Emphasizing the dependence on cell surface-associated receptors, these observations provide evidence for the existence of a steroid receptor fast-action complex, or SRFC, in caveolae.",
keywords = "Caveolae, Endothelium, Estrogen, Estrogen receptor, G protein, Nitric oxide synthase, Steroid",
author = "Chambliss, {Ken L.} and Shaul, {Philip W.}",
year = "2002",
doi = "10.1016/S0039-128X(01)00177-5",
language = "English (US)",
volume = "67",
pages = "413--419",
journal = "Steroids",
issn = "0039-128X",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Rapid activation of endothelial NO synthase by estrogen

T2 - Evidence for a steroid receptor fast-action complex (SRFC) in caveolae

AU - Chambliss, Ken L.

AU - Shaul, Philip W.

PY - 2002

Y1 - 2002

N2 - Estrogen has important atheroprotective and vasoactive properties related to its capacity to stimulate nitric oxide (NO) production by endothelial NO synthase. Previous work has shown that these effects are mediated by estrogen receptor (ER) α functioning in a nongenomic manner via calcium-dependent, MAP kinase-dependent mechanisms. Recent studies have demonstrated that estradiol (E2) activates eNOS in isolated endothelial plasma membranes in the absence of added calcium, calmodulin or eNOS cofactors. Studies of blockade by ICI 182,780 and by ERα antibody, and also immunoidentification experiments indicate that the process is mediated by a subpopulation of plasma membrane-associated ERα. Fractionation of endothelial cell plasma membranes has further revealed that ERα protein is localized to caveolae, and that E2 causes stimulation of eNOS in isolated caveolae which is ER-dependent and calcium-dependent, whereas noncaveolae membranes are insensitive. Furthermore, in intact endothelial cells the activation of eNOS by E2 is prevented by pertussis toxin, and exogenous GDPβS inhibits the response in isolated plasma membranes. Coimmunoprecipitation studies have shown that E2 exposure causes interaction between ERα and Gαi on the plasma membrane, and eNOS activation by E2 is enhanced by overexpression of Gαi and attenuated by expression of a protein regulator of G protein signaling (RGS), RGS4. Thus, a subpopulation of ERα is localized to caveolae in endothelial cells, where they are coupled via Gαi to eNOS in a functional signaling module. Emphasizing the dependence on cell surface-associated receptors, these observations provide evidence for the existence of a steroid receptor fast-action complex, or SRFC, in caveolae.

AB - Estrogen has important atheroprotective and vasoactive properties related to its capacity to stimulate nitric oxide (NO) production by endothelial NO synthase. Previous work has shown that these effects are mediated by estrogen receptor (ER) α functioning in a nongenomic manner via calcium-dependent, MAP kinase-dependent mechanisms. Recent studies have demonstrated that estradiol (E2) activates eNOS in isolated endothelial plasma membranes in the absence of added calcium, calmodulin or eNOS cofactors. Studies of blockade by ICI 182,780 and by ERα antibody, and also immunoidentification experiments indicate that the process is mediated by a subpopulation of plasma membrane-associated ERα. Fractionation of endothelial cell plasma membranes has further revealed that ERα protein is localized to caveolae, and that E2 causes stimulation of eNOS in isolated caveolae which is ER-dependent and calcium-dependent, whereas noncaveolae membranes are insensitive. Furthermore, in intact endothelial cells the activation of eNOS by E2 is prevented by pertussis toxin, and exogenous GDPβS inhibits the response in isolated plasma membranes. Coimmunoprecipitation studies have shown that E2 exposure causes interaction between ERα and Gαi on the plasma membrane, and eNOS activation by E2 is enhanced by overexpression of Gαi and attenuated by expression of a protein regulator of G protein signaling (RGS), RGS4. Thus, a subpopulation of ERα is localized to caveolae in endothelial cells, where they are coupled via Gαi to eNOS in a functional signaling module. Emphasizing the dependence on cell surface-associated receptors, these observations provide evidence for the existence of a steroid receptor fast-action complex, or SRFC, in caveolae.

KW - Caveolae

KW - Endothelium

KW - Estrogen

KW - Estrogen receptor

KW - G protein

KW - Nitric oxide synthase

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=0036230688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036230688&partnerID=8YFLogxK

U2 - 10.1016/S0039-128X(01)00177-5

DO - 10.1016/S0039-128X(01)00177-5

M3 - Article

C2 - 11960616

AN - SCOPUS:0036230688

VL - 67

SP - 413

EP - 419

JO - Steroids

JF - Steroids

SN - 0039-128X

IS - 6

ER -